1. Home
  2. PRQR vs GHI Comparison

PRQR vs GHI Comparison

Compare PRQR & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.11

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Logo Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

GHI

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

HOLD

Current Price

$7.25

Market Cap

254.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
GHI
Founded
2012
1998
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
250.7M
254.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
GHI
Price
$2.11
$7.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$8.14
$13.00
AVG Volume (30 Days)
604.4K
172.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
20.84%
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
$18,859,556.00
$26,247,399.00
Revenue This Year
N/A
$201.02
Revenue Next Year
N/A
$2.87
P/E Ratio
N/A
$42.09
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$6.01
52 Week High
$3.10
$13.29

Technical Indicators

Market Signals
Indicator
PRQR
GHI
Relative Strength Index (RSI) 44.07 53.58
Support Level $2.15 $6.30
Resistance Level $2.49 $7.44
Average True Range (ATR) 0.17 0.27
MACD 0.00 0.14
Stochastic Oscillator 31.30 71.08

Price Performance

Historical Comparison
PRQR
GHI

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: